blood clot; Vertigo; Nausea; Vomiting; A spontaneous report, was received from a consumer concerning a 53 year old female patient who received Moderna's COVID-19 Vaccine (mRNA-1273), and experienced vertigo , nausea, vomiting  and also developed a blood clot (thrombosis) during hospitalization.  Patient had no medical history. The concomitant medication included were zolpidem tartrate 10mg nightly, allopurinol 100mg daily, duloxetine 50mg daily, multivitamin, vitamin d and acetylsalicylic acid 81mg.   On 05 Feb 2021, prior to the onset of events, the patient received the first of two planned doses of mRNA-1273 (Batch no- 010MZ0A), intramuscularly in the left upper arm for prophylaxis of COVID-19 infection.  On 17 Feb 2021, few days after administering the vaccine, the consumer experienced vertigo related nausea and vomiting. The patient was hospitalized for two days and experienced a blood clot during hospitalization. Patient was treated with only diazepam on first two days of treatment. In hospital, patient was given meclizine, diazepam and other anti-nausea medication whereas at home, patient was treated with ondansetron 8 mg, meclizine and diazepam.   On 05 Mar 2021, the patient received the second of two planned doses of mRNA-1273 (Batch no- 036A21A), intramuscularly in the left upper arm for prophylaxis of COVID-19 infection.  The action taken with the second dose of mRNA-1273 in response to the event was not applicable.  The outcome of the events, vertigo, nausea, vomiting was not recovered whereas the outcome of blood clot was unknown at the time of the report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.